What is LOPJLB’s current signal on BFRI?

LOPJLB’s latest quantitative signal on Biofrontera Inc. (BFRI) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is BFRI in?

Biofrontera Inc. (BFRI) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Biofrontera Inc. (BFRI) do?

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquar…